True Private Wealth Advisors Crispr Therapeutics Ag Transaction History

True Private Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$110.72 - $210.04 $11,072 - $21,004	-100 Closed	0 $0
Q4 2020 Jan 11, 2021	BUY	$79.67 - $173.23 $7,967 - $17,323	100 New	100 $15,000
Q1 2020 Apr 20, 2020	SELL	$33.68 - $62.53 $1,616 - $3,001	-48 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$36.68 - $73.13 $1,760 - $3,510	48 New	48 $2,000
Q3 2019 Oct 09, 2019	SELL	$40.99 - $52.56 $1,967 - $2,522	-48 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$35.45 - $48.2 $1,701 - $2,313	48 New	48 $2,000
Q4 2018 Jan 14, 2019	SELL	$22.73 - $42.34 $62,462 - $116,350	-2,748 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$44.35 - $65.71 $121,873 - $180,571	2,748 New	2,748 $0

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.